Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Alex Schwartz's Stock Ratings
Stifel Analyst
Alex Schwartz is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/13/2025
Overall Average Return
9.19%
Smart Score
Overall Average Return Percentile
58th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/21/2024 | ANAB | Buy Now | AnaptysBio | $23.32 | 114.41% | Alex Schwartz42% | → $50 | Initiates | → Buy | Get Alert |
| 09/14/2018 | ANAB | Buy Now | AnaptysBio | $23.32 | 444.6% | Alex Schwartz42% | → $127 | Reinstates | → Buy | Get Alert |
| 04/10/2018 | VTVT | Buy Now | vTv Therapeutics | $15.90 | — | Alex Schwartz42% | — | Downgrade | Buy → Hold | Get Alert |
| 03/27/2018 | ANAB | Buy Now | AnaptysBio | $23.32 | 551.8% | Alex Schwartz42% | $139 → $152 | Maintains | Buy | Get Alert |
| 03/19/2018 | GERN | Buy Now | Geron | $1.52 | 163.16% | Alex Schwartz42% | $2.5 → $4 | Maintains | Hold | Get Alert |
| 03/09/2018 | PBYI | Buy Now | Puma Biotechnology | $3.31 | 2773.74% | Alex Schwartz42% | $85 → $95 | Maintains | Buy | Get Alert |
| 03/06/2018 | ANAB | Buy Now | AnaptysBio | $23.32 | 496.05% | Alex Schwartz42% | $130 → $139 | Maintains | Buy | Get Alert |
| 02/27/2018 | CLVS | Buy Now | Clovis Oncology | — | — | Alex Schwartz42% | $125 → $110 | Maintains | Buy | Get Alert |
| 09/21/2016 | PBYI | Buy Now | Puma Biotechnology | $3.31 | — | Alex Schwartz42% | — | Upgrade | Hold → Buy | Get Alert |
| 08/24/2015 | VTVT | Buy Now | vTv Therapeutics | $15.90 | 6.92% | Alex Schwartz42% | → $17 | Initiates | → Buy | Get Alert |
| 05/18/2015 | CLVS | Buy Now | Clovis Oncology | — | — | Alex Schwartz42% | $90 → $125 | Maintains | Buy | Get Alert |
| 02/26/2015 | CLVS | Buy Now | Clovis Oncology | — | — | Alex Schwartz42% | $75 → $90 | Maintains | Buy | Get Alert |
| 11/07/2014 | CLVS | Buy Now | Clovis Oncology | — | — | Alex Schwartz42% | $50 → $75 | Maintains | Buy | Get Alert |
| 06/05/2014 | CLVS | Buy Now | Clovis Oncology | — | — | Alex Schwartz42% | — | Upgrade | Hold → Buy | Get Alert |
| 12/19/2013 | PBYI | Buy Now | PUMA BIOTECHNOLOGY | $3.31 | — | Alex Schwartz42% | — | Downgrade | Buy → Hold | Get Alert |
| 09/06/2013 | CLVS | Buy Now | Clovis Oncology | — | — | Alex Schwartz42% | — | Initiates | → Hold | Get Alert |
| 08/24/2012 | PBYI | Buy Now | Puma Biotechnology | $3.31 | 474.75% | Alex Schwartz42% | → $19 | Initiates | → Buy | Get Alert |
